WuXi AppTec invests $120mn to build new biologics facility
Biologics | News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2016
Singapore: WuXi AppTec has started construction of an integrated biologics solution center at the company's headquarters...Read more
Aussie firm's new breakthrough in bladder cancer
Biologics | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2015
Singapore: Australia-based startup company Sienna Cancer Diagnostics, has inked a pact with an American pathology compan...Read more
Austrianova inaugurates its Thailand facility
Biologics | News | By BioSpectrum Bureau | 0 Comment | 15 Dec, 2014
Singapore: Austrianova, a Singapore-based cell-encapsulation company recently announced the opening of its manufacturing...Read more
Israel firm gets US, China patent for neuro-peptide
Biologics | News | By BioSpectrum Bureau | 0 Comment | 31 Oct, 2013
Singapore: Israel-based D-Pharm has recieved new patent in the US and China, related to composition and use of THR-18, a...Read more
Singapore scientists find new clues on cervical cancer
Biologics | News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2015
Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI Singapore) at the National University of...Read more
3SBio to develop antibody for acute leukemia
Biologics | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2014
Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA for the develop...Read more
Detect drug resistant TB in a jiffy
Biologics | News | By BioSpectrum Bureau | 0 Comment | 25 Sep, 2014
Singapore: Soon, a simple breath test will detect whether a person is infected with a drug resistant tuberculosis strain...Read more
Breast cancer boasts of highest drug pipeline'
Biologics | News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2014
Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technolo...Read more
AbbVie aquires API manufacturing firm in Singapore
Biologics | News | By BioSpectrum Bureau | 0 Comment | 25 Nov, 2014
Singapore: AbbVie, a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott, h...Read more
Test to detect bird flu mutants
Biologics | News | By BioSpectrum Bureau | 0 Comment | 03 Nov, 2014
Singapore: Australian scientists have developed a new test that can detect bird flu mutation by distinguishing between b...Read more
Biologics | News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2014
Singapore: WHO, in consultation with over 70 experts, is assessing the status of two Ebola vaccine candidates for their ...Read more
Roche to acquire Santaris Pharma for $450 mn
Biologics | News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2014
Singapore: Global biopharmaceutical firm, Roche, is all set to acquire Santaris Pharma, a Denmark based biopharmaceutica...Read more
Beike awaits CFDA nod for stem cell application
Biologics | Regulatory | By BioSpectrum Bureau | 7 Comment | 14 Jul, 2014
Singapore: China-based Beike Biotechnology has recieved Chinese Food and Drug Administration (CFDA) nod for filing the a...Read more
Danish firm, Aussie instiute to co-develop pathological drugs
Biologics | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2013
Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...Read more
WHO sets timeline for ebola vaccine
Biologics | News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2014
Singapore: From September 29-30, 2014, WHO organized an expert consultation to assess the groundwork of ebola vaccine de...Read more
BI to enhance investment in Austria
Biologics | News | By BioSpectrum Bureau | 0 Comment | 28 Dec, 2015
Singapore: Boehringer Ingelheim plans to establish a new large-scale biopharmaceutical production facility for active in...Read more
China Cord Blood gets US accredition
Biologics | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2015
Singapore: Guangdong subsidiary of China Cord Blood Corporation, a provider of cord blood collection, laboratory testing...Read more
Asthma therapy market to touch $23.1 bn by 2023
Biologics | Analysis | By BioSpectrum Bureau | 4 Comment | 08 Sep, 2014
Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countr...Read more